Skip to content 
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified. more
| Time Frame | LABU | S&P500 |
|---|---|---|
| 1-Week Return | -13.92% | -0.77% |
| 1-Month Return | -6.9% | -0.83% |
| 3-Month Return | 49.75% | 3.59% |
| 6-Month Return | 56.13% | 12.95% |
| 1-Year Return | 215.81% | 16.21% |
| 3-Year Return | 170.5% | 70.49% |
| 5-Year Return | -79.44% | 71.13% |
| 10-Year Return | -69.67% | 253.97% |
| Stock name | Ticker | Weight |
|---|---|---|
 SPSIBI SWAP ASSET LEG (SPSIBIUBL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIUBL. | 18.32% |
 SPSIBI SWAP ASSET LEG (SPSIBIBCL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIBCL. | 17.54% |
 SPSIBI SWAP ASSET LEG (SPSIBIMLL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIMLL. | 16.68% |
 SPSIBI SWAP ASSET LEG (SPSIBIJPL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIJPL. | 11.23% |
 DREYFUS GOVT CASH MAN INS | DREYFUS.GOVT.CASH.MAN.INS | 3.97% |
 GOLDMAN FINL SQ TRSRY INST 506 | GOLDMAN.FINL.SQ.TRSRY.INST.506 | 3.9% |
 SPSIBI SWAP ASSET LEG (SPSIBICTL) | SPSIBI.SWAP.ASSET.LEG..SPSIBICTL. | 2.14% |
 SPSIBI SWAP ASSET LEG (SPSIBIBPL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIBPL. | 1.52% |
 SPSIBI SWAP ASSET LEG (SPSIBIGSL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIGSL. | 0.99% |
 GOLDMAN SACHS FIN GOV 465 INSTITUT | GOLDMAN.SACHS.FIN.GOV.465.INSTITUT | 0.95% |
 MODERNA INC | MRNA | 0.65% |
 TWIST BIOSCIENCE CORP | TWST | 0.41% |
 HALOZYME THERAPEUTICS INC | HALO | 0.33% |
 NATERA INC | NTRA | 0.33% |
 KYMERA THERAPEUTICS INC | KYMR | 0.33% |
 TRAVERE THERAPEUTICS INC | TVTX | 0.32% |
 ROIVANT SCIENCES LTD | ROIV | 0.32% |
 ORUKA THERAPEUTICS INC | ORKA | 0.32% |
 REVOLUTION MEDICINES INC | RVMD | 0.31% |
 PRAXIS PRECISION MEDICINES I | PRAX | 0.31% |
 INSMED INC | INSM | 0.31% |
 PROTAGONIST THERAPEUTICS INC | PTGX | 0.3% |
 DIANTHUS THERAPEUTICS INC | DNTH | 0.3% |
 REGENERON PHARMACEUTICALS | REGN | 0.29% |
 CG ONCOLOGY INC | CGON | 0.29% |
 VAXCYTE INC | PCVX | 0.29% |
 SUMMIT THERAPEUTICS INC | SMMT | 0.28% |
 SCHOLAR ROCK HOLDING CORP | SRRK | 0.28% |
 ERASCA INC | ERAS | 0.26% |
 RELAY THERAPEUTICS INC | RLAY | 0.26% |
 RHYTHM PHARMACEUTICALS INC | RYTM | 0.26% |
 GILEAD SCIENCES INC | GILD | 0.26% |
 TG THERAPEUTICS INC | TGTX | 0.26% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.26% |
 SPYRE THERAPEUTICS INC | SYRE | 0.26% |
 VERTEX PHARMACEUTICALS INC | VRTX | 0.26% |
 SELLAS LIFE SCIENCES GROUP I | SLS | 0.26% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.26% |
 INCYTE CORP | INCY | 0.26% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 0.26% |
 VIKING THERAPEUTICS INC | VKTX | 0.26% |
 ABBVIE INC | ABBV | 0.25% |
 AMGEN INC | AMGN | 0.25% |
 MADRIGAL PHARMACEUTICALS INC | MDGL | 0.25% |
 GRAIL INC | GRAL | 0.24% |
 BIOGEN INC | BIIB | 0.24% |
 ACADIA PHARMACEUTICALS INC | ACAD | 0.24% |
 KRYSTAL BIOTECH INC | KRYS | 0.24% |
 CYTOKINETICS INC | CYTK | 0.24% |
 EXELIXIS INC | EXEL | 0.24% |
 COGENT BIOSCIENCES INC | COGT | 0.24% |
 BRIDGEBIO PHARMA INC | BBIO | 0.24% |
 MIRUM PHARMACEUTICALS INC | MIRM | 0.24% |
 UNIQURE NV | QURE | 0.24% |
 CRISPR THERAPEUTICS AG | CRSP | 0.23% |
 ALKERMES PLC | ALKS | 0.23% |
 IMMUNOVANT INC | IMVT | 0.22% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 0.21% |
 CELCUITY INC | CELC | 0.21% |
 IMMUNITYBIO INC | IBRX | 0.21% |
 UNITED THERAPEUTICS CORP | UTHR | 0.2% |
 SAREPTA THERAPEUTICS INC | SRPT | 0.2% |
 PTC THERAPEUTICS INC | PTCT | 0.2% |
 VERA THERAPEUTICS INC | VERA | 0.2% |
 VIRIDIAN THERAPEUTICS INC | VRDN | 0.19% |
 IDEAYA BIOSCIENCES INC | IDYA | 0.19% |
 ALNYLAM PHARMACEUTICALS INC | ALNY | 0.19% |
 MINERALYS THERAPEUTICS INC | MLYS | 0.18% |
 BEAM THERAPEUTICS INC | BEAM | 0.18% |
 BIOCRYST PHARMACEUTICALS INC | BCRX | 0.18% |
 CELLDEX THERAPEUTICS INC | CLDX | 0.17% |
 DYNE THERAPEUTICS INC | DYN | 0.17% |
 IONIS PHARMACEUTICALS INC | IONS | 0.17% |
 IMMUNOME INC | IMNM | 0.17% |
 DENALI THERAPEUTICS INC | DNLI | 0.16% |
 ADMA BIOLOGICS INC | ADMA | 0.16% |
 DISC MEDICINE INC | IRON | 0.16% |
 NOVAVAX INC | NVAX | 0.15% |
 RECURSION PHARMACEUTICALS-A | RXRX | 0.15% |
 HYPERLIQUID STRATEGIES | PURR | 0.15% |
 INTELLIA THERAPEUTICS INC | NTLA | 0.15% |
 ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.15% |
 ARCUS BIOSCIENCES INC | RCUS | 0.15% |
 TANGO THERAPEUTICS INC | TNGX | 0.15% |
 AGIOS PHARMACEUTICALS INC | AGIO | 0.15% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.15% |
 NURIX THERAPEUTICS INC | NRIX | 0.14% |
 VERACYTE INC | VCYT | 0.14% |
 PALVELLA THERAPEUTICS INC | PVLA | 0.14% |
 CAREDX INC | CDNA | 0.13% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.12% |
 VIR BIOTECHNOLOGY INC | VIR | 0.12% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.11% |
 KODIAK SCIENCES INC | KOD | 0.11% |
 BIOHAVEN LTD | BHVN | 0.11% |
 PRECIGEN INC | PGEN | 0.11% |
 XENCOR INC | XNCR | 0.1% |
 STOKE THERAPEUTICS INC | STOK | 0.1% |
 VERICEL CORP | VCEL | 0.1% |
 INHIBRX BIOSCIENCES INC | INBX | 0.1% |
 ANAPTYSBIO INC | ANAB | 0.1% |
 ABSCI CORP | ABSI | 0.09% |
 ZENAS BIOPHARMA INC | ZBIO | 0.09% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.09% |
 VOR BIOPHARMA INC | VOR | 0.09% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.08% |
 REPLIMUNE GROUP INC | REPL | 0.08% |
 KURA ONCOLOGY INC | KURA | 0.08% |
 FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.08% |
 AVALO THERAPEUTICS INC | AVTX | 0.08% |
 JANUX THERAPEUTICS INC | JANX | 0.08% |
 TYRA BIOSCIENCES INC | TYRA | 0.07% |
 MANNKIND CORP | MNKD | 0.07% |
 RIGEL PHARMACEUTICALS INC | RIGL | 0.07% |
 MONTE ROSA THERAPEUTICS INC | GLUE | 0.07% |
 GERON CORP | GERN | 0.07% |
 JADE BIOSCIENCES INC | JBIO | 0.07% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.06% |
 TAYSHA GENE THERAPIES INC | TSHA | 0.06% |
 ARDELYX INC | ARDX | 0.06% |
 IMMIX BIOPHARMA INC | IMMX | 0.06% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.06% |
 ALTIMMUNE INC | ALT | 0.06% |
 VERASTEM INC | VSTM | 0.06% |
 ANNEXON INC | ANNX | 0.06% |
 BICARA THERAPEUTICS INC | BCAX | 0.06% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.06% |
 SOLID BIOSCIENCES INC | SLDB | 0.05% |
 CANDEL THERAPEUTICS INC | CADL | 0.05% |
 SANA BIOTECHNOLOGY INC | SANA | 0.05% |
 IRONWOOD PHARMACEUTICALS INC | IRWD | 0.05% |
 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.05% |
 ALLOGENE THERAPEUTICS INC | ALLO | 0.05% |
 DAMORA THERAPEUTICS INC | DAMORA.THERAPEUTICS.INC | 0.04% |
 ARBUTUS BIOPHARMA CORP | ABUS | 0.04% |
 CAPRICOR THERAPEUTICS INC | CAPR | 0.04% |
 PRIME MEDICINE INC | PRME | 0.04% |
 SAVARA INC | SVRA | 0.04% |
 REGENXBIO INC | RGNX | 0.04% |
 CABALETTA BIO INC | CABA | 0.03% |
 OCUGEN INC | OCGN | 0.03% |
 COMPASS THERAPEUTICS INC | CMPX | 0.03% |
 MIMEDX GROUP INC | MDXG | 0.03% |
 PROTHENA CORP PLC | PRTA | 0.03% |
 OVID THERAPEUTICS INC | OVID | 0.03% |
 ARS PHARMACEUTICALS INC | SPRY | 0.03% |
 VANDA PHARMACEUTICALS INC | VNDA | 0.03% |
 PERSPECTIVE THERAPEUTICS INC | CATX | 0.02% |
 SAGIMET BIOSCIENCES INC-A | SGMT | 0.02% |
 LEXEO THERAPEUTICS INC | LXEO | 0.02% |
 MYRIAD GENETICS INC | MYGN | 0.02% |
 EMERGENT BIOSOLUTIONS INC | EBS | 0.02% |
 ACHIEVE LIFE SCIENCES INC | ACHV | 0.02% |
 MAPLIGHT THERAPEUTICS INC | MPLT | 0.02% |
 DREYFUS TRSRY SECURITIES CASH MGMT | DREYFUS.TRSRY.SECURITIES.CASH.MGMT | 0.01% |
 SIONNA THERAPEUTICS INC | SION | 0.01% |
 BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 0.01% |
 VERVE THERAPEUTICS INC (CVR) | VERVE.THERAPEUTICS.INC..CVR. | 0% |
 NOVOB DC CVR | NOVOB.DC.CVR | 0% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
 INHIBRX INC CVR | INHIBRX.INC.CVR | 0% |
 OMNIAB INC - 15.00 EARNOUT | 2200964 | 0% |
| Sector | Weight |
|---|---|
|
Health care | 99.27% |
|
Financials | 0.73% |
Direxion Daily S&P Biotech Bull 3X Shares (LABU) share price today is $272.46.
Yes, Indians can buy shares of Direxion Daily S&P Biotech Bull 3X Shares (LABU) on Vested. To buy LABU from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Direxion Daily S&P Biotech Bull 3X Shares (LABU) on Vested. You can start investing in Direxion Daily S&P Biotech Bull 3X Shares (LABU) with a minimum investment of $1.
The 52-week high price of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is $341.93. The 52-week low price of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is $74.48.
The stock symbol (or ticker) of Direxion Daily S&P Biotech Bull 3X Shares is LABU.
Yes, you can setup SIP in Direxion Daily S&P Biotech Bull 3X Shares shares. Follow the below steps to create the SIP:
Here is the historical performance of LABU on the Vested app.
The expense ratio of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is 0.96%.
Link copied 
